Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

Journal of Infectious Diseases - Tập 203 Số 6 - Trang 780-790 - 2011
Netanya S. Utay1, Handan Wand2, Annelys Roque1, Matthew Law2, Martha Nason3, Daniel E. Nixon4, Court Pedersen5, Kiat Ruxrungtham6, Sharon R. Lewin7,8,9, Sean Emery2, James D. Neaton10, Jason M. Brenchley3, Steven G. Deeks11, Irini Sereti3, Daniel C. Douek1
1National Institutes of Health, Bethesda
2University of New South Wales
3NATIONAL INSTITUTES OF HEALTH
4Virginia Commonwealth University
5 University of Southern Denmark
6Chulalongkorn University
7Alfred Hospital
8Burnet Institute
9Monash University
10University of Minnesota
11University of California at San Francisco

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hellerstein, 1999, Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans, Nat Med, 5, 83, 10.1038/4772

Hazenberg, 2000, T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART), Blood, 95, 249, 10.1182/blood.V95.1.249

Valdez, 1997, Cytokines and cytokine therapies in HIV infection, AIDS Clin Rev, 187

Wilson, 2004, CD8+CD38+ T cells but not HIV type 1 RNA viral load predict CD4+ T cell loss in a predominantly minority female HIV+ adolescent population, AIDS Res Hum Retroviruses, 20, 263, 10.1089/088922204322996482

Deeks, 2004, The immune response to AIDS virus infection: good, bad, or both?, J Clin Invest, 113, 808, 10.1172/JCI200421318

Hunt, 2003, T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy, J Infect Dis, 187, 1534, 10.1086/374786

Giorgi, 1999, Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage, J Infect Dis, 179, 859, 10.1086/314660

Ford, 2009, Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm, Curr Opin HIV AIDS, 4, 206, 10.1097/COH.0b013e328329c68c

Veazey, 1998, Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection, Science, 280, 427, 10.1126/science.280.5362.427

Brenchley, 2004, CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract, J Exp Med, 200, 749, 10.1084/jem.20040874

Scamurra, 2002, Mucosal plasma cell repertoire during HIV-1 infection, J Immunol, 169, 4008, 10.4049/jimmunol.169.7.4008

Li, 2008, Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection, J Infect Dis, 197, 420, 10.1086/525046

Brenchley, 2006, HIV disease: fallout from a mucosal catastrophe?, Nat Immunol, 7, 235, 10.1038/ni1316

Gioannini, 2007, Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells, Immunol Res, 39, 249, 10.1007/s12026-007-0069-0

Miller, 2005, TLR4 and infectious disease diversity, Nat Rev Microbiol, 3, 36, 10.1038/nrmicro1068

Miyake, 2006, Roles for accessory molecules in microbial recognition by Toll-like receptors, J Endotoxin Res, 12, 195, 10.1179/096805106X118807

Brenchley, 2006, Microbial translocation is a cause of systemic immune activation in chronic HIV infection, Nat Med, 12, 1365, 10.1038/nm1511

Jiang, 2009, Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection, J Infect Dis, 199, 1177, 10.1086/597476

El-Sadr, 2006, CD4+ count-guided interruption of antiretroviral treatment, N Engl J Med, 355, 2283, 10.1056/NEJMoa062360

Kuller, 2008, Inflammatory and coagulation biomarkers and mortality in patients with HIV infection, PLoS Med, 5, e203, 10.1371/journal.pmed.0050203

Rodger, 2009, Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection, J Infect Dis, 200, 973, 10.1086/605447

Duprez, 2009, Lipoprotein particle subclasses, cardiovascular disease and HIV infection, Atherosclerosis, 207, 524, 10.1016/j.atherosclerosis.2009.05.001

Phillips, 2008, Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial, Antivir Ther, 13, 177, 10.1177/135965350801300215

Pelsers, 2003, Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility, Clin Biochem, 36, 529, 10.1016/S0009-9120(03)00096-1

Landmann, 1996, Human monocyte CD14 is upregulated by lipopolysaccharide, Infect Immun, 64, 1762, 10.1128/IAI.64.5.1762-1769.1996

Hiki, 1998, Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria, Infect Immun, 66, 1135, 10.1128/IAI.66.3.1135-1141.1998

Rodriguez, 2006, Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection, JAMA, 296, 1498, 10.1001/jama.296.12.1498

Marchetti, 2008, Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy, AIDS, 22, 2035, 10.1097/QAD.0b013e3283112d29

Raj, 2009, Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis, Am J Kidney Dis, 54, 1062, 10.1053/j.ajkd.2009.06.028

Deeks, 2004, Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, 104, 942, 10.1182/blood-2003-09-3333

Liu, 1997, Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression, J Acquir Immune Defic Syndr Hum Retrovirol, 16, 83, 10.1097/00042560-199710010-00003

Voss, 2006, A CD14 domain with lipopolysaccharide-binding and -neutralizing activity, Chembiochem, 7, 275, 10.1002/cbic.200500257

Talwar, 2006, Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans, Physiol Genomics, 25, 203, 10.1152/physiolgenomics.00192.2005

Hailman, 1996, Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14, J Immunol, 156, 4384, 10.4049/jimmunol.156.11.4384

Jirillo, 1998, Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-alpha, mmunopharmacol Immunotoxicol, 20, 1, 10.3109/08923979809034805

Scuderi, 2003, Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus, Autoimmunity, 36, 71, 10.1080/0891693031000079275

Takeshita, 2000, Increased levels of circulating soluble CD14 in Kawasaki disease, Clin Exp Immunol, 119, 376, 10.1046/j.1365-2249.2000.01120.x

Kudlova, 2007, Lipopolysaccharide binding protein and sCD14 are not produced as acute phase proteins in cardiac surgery, Mediators Inflamm, 72356, 1, 10.1155/2007/72356

Wallet, 2010, Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy, AIDS, 24, 1281, 10.1097/QAD.0b013e328339e228

Rajasuriar, 2010, Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation, J Infect Dis, 202, 1254, 10.1086/656369

Lahiri, 1993, DNA isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality, Biochem Genet, 31, 321, 10.1007/BF00553174

Heumann, 2002, Initial responses to endotoxins and gram-negative bacteria, Clin Chim Acta, 323, 59, 10.1016/S0009-8981(02)00180-8

Cross, 2001, Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis, J Infect Dis, 183, 1079, 10.1086/319297

Kitchens, 2001, Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins, J Clin Invest, 108, 485, 10.1172/JCI200113139

Ketchum, 2000, Assay of endotoxin by Limulus Amebocyte Lysate, Methods Mol Med, 36, 3

Eichbaum, 1991, Chylomicrons can inhibit endotoxin activity in vitro, J Surg Res, 51, 413, 10.1016/0022-4804(91)90143-A

Henckaerts, 2009, Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit, Crit Care Med, 37, 192, 10.1097/CCM.0b013e31819263d8

Campos, 2005, The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers, Alcohol Clin Exp Res, 29, 1206, 10.1097/01.ALC.0000171977.25531.7A

Meiler, 2005, Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection, World J Gastroenterol, 11, 6031, 10.3748/wjg.v11.i38.6031

Kotler, 1984, Enteropathy associated with the acquired immunodeficiency syndrome, Ann Intern Med, 101, 421, 10.7326/0003-4819-101-4-421